Is this you? Create Your Porfile
Avatar

Alain Claude-Marie Daugan

Icos

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Alain Claude-Marie Daugan is active.

Explore More

Publication

Featured researches published by Alain Claude-Marie Daugan.

Archive | 1995

Tetracyclic derivatives; process of preparation and use

Alain Claude-Marie Daugan

Journal of Medicinal Chemistry | 2003

The discovery of tadalafil: A novel and highly selective PDE5 inhibitor. 2: 2,3,6,7,12,12a-hexahydropyrazino[1', 2':1,6]pyrido[3,4-b]indole-1,4-dione analogues

Alain Claude-Marie Daugan; Pascal Grondin; Cécile Ruault; Anne‐Charlotte le Monnier de Gouville; Hervé Coste; Jean Michel Linget; Jorge Kirilovsky; Francois Hyafil; Richard Labaudiniere

Journal of Medicinal Chemistry | 2003

The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 1: 5,6,11,11a-tetrahydro-1H-imidazo[1',5':1,6]pyrido[3,4-b]indole-1,3(2H)-dione analogues.

Alain Claude-Marie Daugan; Pascal Grondin; Cécile Ruault; Anne‐Charlotte le Monnier de Gouville; Hervé Coste; Jorge Kirilovsky; Francois Hyafil; Richard Labaudiniere

Archive | 1998

Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use

Alain Claude-Marie Daugan; Françoise Gellibert

Archive | 1996

Use of cGMP-phosphodiesterase inhibitors in methods and compositions to treat impotence

Alain Claude-Marie Daugan

Archive | 2001

Use of therapeutic benzamide derivatives

Alain Claude-Marie Daugan; Jorge Kirilovsky

Archive | 2001

Tetracyclic diketopiperazine compounds as pdev inhibitors

Mark W. Orme; Alain Claude-Marie Daugan; Agnes Bombrun

Archive | 1999

Treatment method using a cGMP-Specific PDE inhibitor

Alain Claude-Marie Daugan; Richard Frédéric Labaudiniere

Archive | 1999

Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents

Alain Claude-Marie Daugan; Françoise Gellibert

Archive | 2000

Use of cGMP phosphodiesterase inhibitors in methods to treat female sexual dysfunction

Alain Claude-Marie Daugan

Explore More

Collaboration

Dive into the Alain Claude-Marie Daugan's collaboration.

Top Co-Authors
Avatar

Françoise Gellibert

Icos

View shared research outputs
Top Co-Authors
Avatar

Mark W. Orme

Icos

View shared research outputs
Top Co-Authors
Avatar

Jason Scott Sawyer

Icos

View shared research outputs
Top Co-Authors
Avatar

Richard Labaudiniere

Rhône-Poulenc

View shared research outputs
Top Co-Authors
Avatar

Lisa M. Schultze

Icos

View shared research outputs
Top Co-Authors
Avatar

Jorge Kirilovsky

GlaxoSmithKline

View shared research outputs
Top Co-Authors
Avatar

Anne‐Charlotte le Monnier de Gouville

Rhône-Poulenc

View shared research outputs
Top Co-Authors
Avatar

Francois Hyafil

Pasteur Institute

View shared research outputs
Top Co-Authors
Avatar

Hervé Coste

Pasteur Institute

View shared research outputs
Top Co-Authors
Avatar

Agnes Bombrun

Icos

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge